Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population impact of pharmacogenetic tests in admixed populations across the Americas.

The pharmacogenomics journal - 1 Apr 2021

Suarez-Kurtz Guilherme

Abstract excerpt

The current population of the Americas (~1 billion people) is highly heterogeneous as a result of five centuries of admixture between three major parental populations, namely Native Amerindians, Europeans, and subSaharan Africans. This heterogeneity has important pharmacogenetic (PGx) implications. The present study explores this issue with respect to the population impact of PGx tests listed in the CPIC and DWPG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Americas
Share to Black People
Share to Brazil

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Pharmacogenetics

Share to Pharmacogenomic Testing

Share to Polymorphism, Single Nucleotide

Share to White People

Source

Identifiers

PMID: 33110249
DOI: 10.1038/s41397-020-00200-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population impact of pharmacogenetic tests in admixed populations across the Americas.PMID 33110249Read ↗

Pharmacogeomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing.Semantic proximity Read ↗

Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT 15 Genotypes: 2018 UpdateSemantic proximity Read ↗

Genotyping of DPYD and UGT1A1 in Brazilian oncological patients: applying pharmacogenomics in an admixed population.Semantic proximity Read ↗

Diversity of oncopharmacogenetic profile within Spanish population.Semantic proximity Read ↗

NUDT15 c.415C>T (rs116855232) Allele Frequency and Estimated Thiopurine Metabolizer Phenotype Distribution in the Iranian Population: A Study Based on Public Genomic DataSemantic proximity Read ↗

NUDT15 and TPMT polymorphisms in three distinct native populations of the Brazilian AmazonSemantic proximity Read ↗

Comprehensive overview of the global pharmacogenetic and functional variability in NUDT15.Semantic proximity Read ↗

TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.Semantic proximity Read ↗

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical PracticeSemantic proximity Read ↗

Germline oncopharmacogenetics, a promising field in cancer therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.